Terms: = Germ cell tumor AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254 AND Treatment
16 results:
1. Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma.
Pennington TE; Zhao CY; Colebatch AJ; Fernandez-Peñas P; Guitera P; Burke H; Scolyer RA; Menzies AM; Carlino MS; Lo S; Long GV; Saw RP
Australas J Dermatol; 2022 May; 63(2):e133-e137. PubMed ID: 35188271
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive Genomic Analysis of Noonan Syndrome and Acute Myeloid Leukemia in Adults: A Review and Future Directions.
Alhumaid MS; Dasouki MJ; Ahmed SO; AbalKhail H; Hagos S; Wakil S; Hashmi SK
Acta Haematol; 2020; 143(6):583-593. PubMed ID: 32541138
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
Yang F; Anekpuritanang T; Press RD
Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
[TBL] [Abstract] [Full Text] [Related]
4. npm1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors.
Phi JH; Sun CH; Lee SH; Lee S; Park I; Choi SA; Park SH; Lee JY; Wang KC; Kim SK; Yun H; Park CK
BMC Cancer; 2019 Aug; 19(1):848. PubMed ID: 31462227
[TBL] [Abstract] [Full Text] [Related]
5. New primary melanoma in a patient under triple therapy with vemurafenib, cobimetinib, and atezolizumab for metastatic melanoma.
Diamantopoulos PT; Lakiotaki E; Kyriakakis G; Gogas H
Melanoma Res; 2020 Apr; 30(2):206-208. PubMed ID: 31157737
[TBL] [Abstract] [Full Text] [Related]
6. Lorlatinib treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer.
Redaelli S; Ceccon M; Zappa M; Sharma GG; Mastini C; Mauri M; Nigoghossian M; Massimino L; Cordani N; Farina F; Piazza R; Gambacorti-Passerini C; Mologni L
Cancer Res; 2018 Dec; 78(24):6866-6880. PubMed ID: 30322862
[TBL] [Abstract] [Full Text] [Related]
7. Cancer stem cell markers in glioblastoma - an update.
Xu HS; Qin XL; Zong HL; He XG; Cao L
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3207-3211. PubMed ID: 28770964
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
[TBL] [Abstract] [Full Text] [Related]
9. npm1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape.
Holmberg Olausson K; Elsir T; Moazemi Goudarzi K; Nistér M; Lindström MS
Sci Rep; 2015 Nov; 5():16495. PubMed ID: 26559910
[TBL] [Abstract] [Full Text] [Related]
10. Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma.
Dolman ME; Poon E; Ebus ME; den Hartog IJ; van Noesel CJ; Jamin Y; Hallsworth A; Robinson SP; Petrie K; Sparidans RW; Kok RJ; Versteeg R; Caron HN; Chesler L; Molenaar JJ
Clin Cancer Res; 2015 Nov; 21(22):5100-9. PubMed ID: 26202950
[TBL] [Abstract] [Full Text] [Related]
11. Medullospheres from DAOY, UW228 and ONS-76 cells: increased stem cell population and proteomic modifications.
Zanini C; Ercole E; Mandili G; Salaroli R; Poli A; Renna C; Papa V; Cenacchi G; Forni M
PLoS One; 2013; 8(5):e63748. PubMed ID: 23717474
[TBL] [Abstract] [Full Text] [Related]
12. Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines.
Del Grosso F; De Mariano M; Passoni L; Luksch R; Tonini GP; Longo L
BMC Cancer; 2011 Dec; 11():525. PubMed ID: 22192458
[TBL] [Abstract] [Full Text] [Related]
13. Localization of nucleophosmin in nuclear matrix and changes in its expression during the differentiation of human neuroblastoma induced by retinoic acid.
Shi SL; Liang Y; Li QF; Liu QR; Jing GJ; Wang SY; Zhang XY; Wu FY
J Cell Biochem; 2010 Sep; 111(1):67-74. PubMed ID: 20506166
[TBL] [Abstract] [Full Text] [Related]
14. The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
Kelleher FC; McDermott R
Eur J Cancer; 2010 Sep; 46(13):2357-68. PubMed ID: 20451371
[TBL] [Abstract] [Full Text] [Related]
15. Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992.
Cotterill SJ; Pearson AD; Pritchard J; Foot AB; Roald B; Kohler JA; Imeson J
Eur J Cancer; 2000 May; 36(7):901-8. PubMed ID: 10785596
[TBL] [Abstract] [Full Text] [Related]
16. Combinatorial effects of monoclonal anti-p120 antibody (MAbp120), liposomes and hyperthermia on MCF-7 and LOX tumor cell lines.
Perlaky L; Busch RK; Busch H
Oncol Res; 1996; 8(9):363-9. PubMed ID: 8979270
[TBL] [Abstract] [Full Text] [Related]
